Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
Ahmed Babiker, Charles Marvil, Jesse J. Waggoner, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 4
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Daryl Geers, Marc C. Shamier, Susanne Bogers, et al.
Science Immunology (2021) Vol. 6, Iss. 59
Open Access | Times Cited: 524
COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection
Kevin Escandón-Vargas, Angela L. Rasmussen, Isaac I. Bogoch, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 168
Main differences between the first and second waves of COVID-19 in Madrid, Spain
Vincent Soriano, Pilar Ganado-Pinilla, Miguel Sánchez-Santos, et al.
International Journal of Infectious Diseases (2021) Vol. 105, pp. 374-376
Open Access | Times Cited: 117
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: Meta‐analysis
Maria Elena Flacco, Cecilia Acuti Martellucci, Valentina Baccolini, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 10
Open Access | Times Cited: 78
Severe Reinfection With South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant 501Y.V2
Noémie Zucman, Fabrice Uhel, Diane Descamps, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 10, pp. 1945-1946
Open Access | Times Cited: 92
Three SARS-CoV-2 reinfection cases by the new Variant of Concern (VOC) P.1/501Y.V3
Felipe Gomes Naveca, Cristiano Fernandes da Costa, Valdinete Alves do Nascimento, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 91
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses
F. Javier Ibarrondo, Christian Hofmann, Jennifer A. Fulcher, et al.
ACS Nano (2021) Vol. 15, Iss. 7, pp. 11180-11191
Closed Access | Times Cited: 81
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Gregory Milne, Thomas Hames, Chris J. Scotton, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1450-1466
Open Access | Times Cited: 79
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
Mars Stone, Eduard Grebe, Hasan Sulaeman, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 672-683
Open Access | Times Cited: 59
How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysis
Ying Chen, Wenhui Zhu, Xinyue Han, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance
Clara Di Germanio, Graham Simmons, Kathleen Kelly, et al.
Transfusion (2021) Vol. 61, Iss. 9, pp. 2677-2687
Open Access | Times Cited: 52
Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020
Paola Cristina Resende, João Felipe Bezerra, Romero Henrique Teixeira Vasconcelos, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 7, pp. 1789-1794
Open Access | Times Cited: 48
Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters
Rachel M. Burckhardt, John J. Dennehy, Leo L. M. Poon, et al.
Journal of Virology (2021) Vol. 96, Iss. 3
Open Access | Times Cited: 47
Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2
Mariana Soares da Silva, Meriane Demoliner, Alana Witt Hansen, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2021) Vol. 63
Open Access | Times Cited: 35
SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
Thomas Theo Brehm, Susanne Pfefferle, Ronald von Possel, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 661-661
Open Access | Times Cited: 32
Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern
Ahmed Babiker, Katherine Immergluck, Samuel D. Stampfer, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 12
Open Access | Times Cited: 29
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
Qi Chen, Kongxin Zhu, Xiaohui Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 793-803
Open Access | Times Cited: 20
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada
Lucie Richard, Rosane Nisenbaum, Karen Colwill, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
Maddalena Peghin, Emilio Bouza, Martina Fabris, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 12, pp. 2597-2604
Open Access | Times Cited: 25
New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil
Lívia R. Góes, Juliana D. Siqueira, Marianne M. Garrido, et al.
Infection Genetics and Evolution (2021) Vol. 94, pp. 104998-104998
Open Access | Times Cited: 24
Postbiotics as potential promising tools for SARS-CoV-2 disease adjuvant therapy
Nader Khani, Roya Abedi Soleimani, Ghasem Noorkhajavi, et al.
Journal of Applied Microbiology (2022) Vol. 132, Iss. 6, pp. 4097-4111
Closed Access | Times Cited: 18
SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study
Maram Alotaibi, Ines Krissaane, Ahad Al Seraihi, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 758-766
Open Access | Times Cited: 17
“Monozygotic twins discordant for severe clinical recurrence of COVID-19 show drastically distinct T cell responses to SARS-Cov-2”
Mateus Vidigal de Castro, Keity Souza Santos, Juliana de Souza Apostólico, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 23
SARS‐CoV‐2 reinfection in a cancer patient with a defective neutralizing humoral response
Cinzia Borgogna, Marco De Andrea, Gloria Griffante, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6444-6446
Open Access | Times Cited: 23
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
David Forgacs, Hyesun Jang, Rodrigo B. Abreu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top